Circle Pharma

Type6 Therapeutics

This deep-tech company develops kinase inhibitors for cancer treatment, intercepting enzymes in their inactive states to address drug resistance for patients with aggressive tumours.

PanTher Therapeutics

This deep-tech company develops polymer-based drug delivery systems for continuous, localised chemotherapy treatment for patients with solid tumours, specifically pancreatic cancer.

PROSION

This deep-tech company develops small molecule inhibitors to target undruggable proteins for patients with cancer and other serious diseases.

Amphista Therapeutics

This company develops targeted protein degradation medicines to treat patients with cancer and other diseases.

Catena Biosciences

This deep-tech company develops protein conjugation technology and multi-payload conjugates to create targeted therapeutics for patients with oncology and autoimmune diseases.

Leash Bio

This deep-tech company generates large-scale biochemical datasets and machine learning models to assist biopharmaceutical partners and internal teams in designing new medicinal drugs.

Tubulis

This deep-tech company develops antibody-drug conjugates to treat patients with solid tumours.

Cartography Biosciences

This deep-tech company develops precision cancer therapeutics and drug targets for healthcare providers using computational biology and machine learning platforms.